Announced Fri, 15 May · 15:49 IST

Audited Financial statements & results for the quarter and year ended 31.03.2026

Revenue Growth 20pctPat NegativeEbitda Margin CompressionDebt Equity ThresholdResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹115.10
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9-2.7-2.3-2.9-2.7-5.3-3.1+19.8
Up moveDown movePending
AI summary

Shree Hari Chemicals Export Limited reported audited standalone revenue of Rs. 18,450.48 Lakhs for FY2026, up 30.7% from Rs. 14,119.58 Lakhs in FY2025. However, standalone net profit declined 17.6% to Rs. 422.22 Lakhs from Rs. 512.40 Lakhs. Consolidated net profit fell 19.2% to Rs. 411.81 Lakhs from Rs. 509.75 Lakhs. The company has two wholly-owned subsidiaries: Shakhambhari Dyechem and Shakhambhari Chemtech. EBITDA margin compressed significantly from 8.13% in FY2025 to approximately 5.31% in FY2026. Borrowings increased substantially with consolidated non-current liabilities rising from Rs. 419.94 Lakhs to Rs. 878.95 Lakhs. The auditor issued an unmodified opinion with no qualifications or emphasis of matter. The company disclosed it qualifies as a Large Corporate under SEBI rules with outstanding qualified borrowings of Rs. 28.38 Crore at year end.

Likely market impact

Strong top-line growth of 30.7% was offset by a 17-19% decline in net profit and significant EBITDA margin compression of nearly 3 percentage points. The sharp increase in borrowings and widening gap between revenue growth and profitability raises concerns about cost efficiency and financial health.